OptimizeRx Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OptimizeRx Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q1 2023.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $2.91M, a 28.5% increase year-over-year.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $16.4M, a 132% increase year-over-year.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2022 was $15.7M, a 187% increase from 2021.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2021 was $5.49M, a 73.1% increase from 2020.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2020 was $3.17M, a 40.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $16.4M $2.91M +$645K +28.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $15.7M $5.17M +$2.3M +79.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-10
Q3 2022 $13.5M $4.28M +$3.27M +324% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $10.2M $4.03M +$3.13M +349% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.05M $2.27M +$1.56M +221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $5.49M $2.88M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.01M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $897K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $707K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.